title: Gigantic vascular anomaly in a PHACE syndrome patient managed with photodynamic therapy.
authors.affiliation: Division of Surgery and Interventional Science, UCL, London, UK. Electronic address: waseem_wk1@yahoo.co.uk.
authors.forename: W
authors.initials: W
authors.lastname: Jerjes
authors.affiliation: Head and Neck Centre, University College London Hospitals, London, UK; Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, UK. Electronic address: zaid19772000@yahoo.com.
authors.forename: Z
authors.initials: Z
authors.lastname: Hamdoon
authors.affiliation: Division of Surgery and Interventional Science, UCL, London, UK. Electronic address: r.hamoudi@ucl.ac.uk.
authors.forename: R
authors.initials: R
authors.lastname: Hamoudi
authors.affiliation: Royal Medical Services, Amman, Jordan. Electronic address: khawalde@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Al-Khawalde
authors.affiliation: Division of Surgery and Interventional Science, UCL, London, UK; Head and Neck Centre, University College London Hospitals, London, UK; Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, UK. Electronic address: c.hopper@ucl.ac.uk.
authors.forename: C
authors.initials: C
authors.lastname: Hopper
mesh_terms: D001017:Aortic Coarctation / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D002648:Child; D005124:Eye Abnormalities / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006391:Hemangioma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D020752:Neurocutaneous Syndromes / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage; D016896:Treatment Outcome; D054079:Vascular Malformations / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D017319:Photosensitizing Agents
keywords: Haemangioma; Meta-tetra-hydroxyphenyl chlorine; PHACE syndrome; Photodynamic therapy; US-iPDT; Vascular anomalies; Vascular tumours